Abstract
An E1, E3 deleted adenovirus vector, serotype 5, carrying the marker gene LacZ was bilaterally microinfused into the caudate nuclei of 10 St Kitts green monkeys. The location and number of cells expressing transgene and host immunologic response were evaluated at 1 week (n = 2) and 1 month (n = 8) following vector infusion. A large number of cells expressed β-galactosidase in some monkeys, exceeding 600000 in one monkey, but no expression was seen in three of 10. All monkeys had positive adenoviral antibody titers before vector infusion, indicating the possibility of previous exposure to some adenovirus, but only one showed a significant increase in titer afterwards. Inflammatory cell markers revealed an inverse correlation between transgene expression and the extent of inflammatory response. Dexamethasone administered immediately before and for 8 days following vector delivery, however, had no effect on transgene expression. The demonstration of significant inflammatory responses in the brain of some individual primates, including demyelination, indicates the need for new generations of adenovirus vectors, or the successful suppression of inflammatory responses, before this vector is suitable for non-cytotoxic clinical applications in the CNS.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Choi-Lundberg DL et al. Dopaminergic neurons protected from degeneration by GDNF gene therapy Science 1997 275: 838–841
Lin WR, Casas I, Wilcock GK, Itzhaki RF . Neurotropic viruses and Alzheimer’s disease – a search for varicella zoster virus DNA by the polymerase chain reaction J Neurol NeurosurgPsychiat 1997 62: 586–589
Davidson BL, Bohn MC . Recombinant adenovirus – a gene transfer vector for study and treatment of CNS diseases Exp Neurol 1997 144: 125–130
Bilang-Bleuel A et al. Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinsons disease Proc Natl Acad Sci USA 1997 94: 8818–8823
Choi-Lundberg DL et al. Behavioral and cellular protection of rat dopaminergic neurons elicted by an adenoviral vector encoding glial cell line-derived neurotrophic factor Exp Neurol 1998 154: 261–275
Betz AL, Yang GY, Davidson BL . Attentuation of stroke size in rats using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist in brain J Cereb Blood Flow Metab 1995 15: 547–551
Yang GY, Zhao YJ, Davidson BL, Betz AL . Overexpression of interleukin-1 receptor antagonist in the mouse brain reduces ischemic brain injury Brain Res 1997 751: 181–188
Akli S et al. Transfer of a foreign gene into the brain using adenovirus vectors (see comments) Natl Genet 1993 3: 224–228
Davidson BL et al. A model system for in vivo gene transfer into the central nervous system using an adenoviral vector (see comments) Nat Genet 1993 3: 219–223
Le Gal La Salle G et al. An adenovirus vector for gene transfer into neurons and glia in the brain Science 1993 259: 988–990
Byrnes AP, Rusby JE, Wood MJ, Charlton HM . Adenovirus gene transfer causes inflammation in the brain Neuroscience 1995 66: 1015–1024
Peltekian E et al. Adenovirus-mediated gene transfer to the brain: methodological assessment (review) J Neurosci Meth 1997 71: 77–84
Kajiwara K et al. Immune responses to adenoviral vectors during gene transfer in the brain Hum Gene Ther 1997 8: 253–265
Wood MJ et al. Immune responses to adenovirus vectors in the nervous system (review) Trends Neurosci 1996 19: 497–501
Byrnes AP, Wood MJ, Charlton HM . Role of T cells in inflammation caused by adenovirus vectors in the brain Gene Therapy 1996 3: 644–651
Horellou P, Sabate O, Bue-Caron MH, Mallet J . Adenovirus-mediated gene transfer to the central nervous system for Parkinson’s disease (review) Exp Neurol 1997 144: 131–138
Smith JG et al. Intracranial administration of adenovirus expressing HSV-TK in combination with ganciclovir produces a dose-dependent, self-limiting inflammatory response Hum Gene Ther 1997 8: 943–954
Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS . Role of transcriptional activation of IkBa in mediation of immunosuppression by glucocorticoids Science 1995 270: 283–286
Yang-Yen HF et al. Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein–protein interaction Cell 1990 62: 1205–1215
Pearce D, Yamamoto KR . Mineralocorticoid and glucocorticoid receptor activities distinguished by nonreceptor factors at a composite response element Science 1993 259: 1161–1165
Bohn MC et al. Adenoviral-mediated transgene expression in non-human primate brain Hum Gene Ther 1999 10: 1175–1184
Goodman JC et al. Adenoviral-mediated thymidine kinase gene transfer into the primate brain followed by systemic ganciclovir: pathologic, radiologic, and molecular studies Hum Gene Ther 1996 7: 1241–1250
Tripathy SK, Black HB, Goldwasser E, Leiden JM . Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors Nature Med 1996 2: 545–550
Abe K, Setoguchi Y, Hayashi T, Itoyama Y . In vivo adenovirus-mediated gene transfer and the expression in ischemic and reperfused rat brain Brain Res 1997 763: 191–201
Hall AR, Dix BR, O’Carroll SJ, Braithwaite AW . p53-dependent cell death/apoptosis is required for a productive adenovirus infection (see comments) Nature Med 1998 4: 1068–1072
Bauer J et al. T-cell apoptosis in inflammatory brain lesions: destruction of T cells does not depend on antigen recognition (see comments) Am J Pathol 1998 153: 715–724
Cuff S, Ruby J . Evasion of apoptosis by DNA viruses (review) Immunol Cell Biol 1996 74: 527–537
Hardwick JM . Virus-induced apoptosis (review) Ad Pharmacol 1997 41: 295–336
Marcellus RC et al. The early region 4 orf 4 protein of human adenovirus type 5 induces p53-independent cell death by apoptosis J Virol 1998 72: 7144–7153
Marcellus RC et al. Adenovirus type 5 early region 4 is responsible for E1A-induced p53-independent apoptosis J Virol 1996 70: 6207–6215
Morimoto K et al. Intrinsic response to Borna virus infection of the central nervous system Proc Natl Acad Sci USA 1996 93: 13345–13350
Durham HD et al. The immunosuppressant fk506 prolongs transgene expression in brain following adenovirus-mediated gene transfer Neuroreport 1997 8: 2111–2115
Stein CS, Pemberton JL, van Rooijen N, Davidson BL . Effects of macrophage depletion and anti-CD40 ligand on transgene expression and redosing with recombinant adenovirus Gene Therapy 1998 5: 431–439
Byrnes AP, MacLaren RE, Charlton HM . Immunological instability of persistent adenovirus vectors in the brain: peripheral exposure to vector leads to renewed inflammation, reduced gene expression, and demyelination J Neurosci 1996 16: 3045–3055
Eck SL et al. Clinical protocol – treatment of advanced CNS malignancies with the recombinant adenovirus h5.010rsvtk – a phase 1 trial Hum Gene Ther 1996 7: 1465–1482
Cirielli C, Capogrossi MC, Passaniti A . Anti-tumor genetherapy J Neuro Oncol 1997 31: 217–223
Lisovoski F et al. Phenotypic alteration of astrocytes induced by ciliary neurotrophic factor in the intact adult brain, as revealed by adenovirus-mediated gene transfer J Neurosci 1997 17: 7228–7236
Maron A et al. Differential toxicity of ganciclovir for rat neurons and astrocytes in primary culture following adenovirus-mediated transfer of the HSVtk gene Gene Therapy 1997 4: 25–31
Kaplan JM et al. Humoral and cellular immune responses of nonhuman primates to long-term repeated exposure to Ad2/CFTR-2 Gene Therapy 1996 3: 117–127
Jooss K, Yang Y, Wilson JM . Cyclophosphamide diminishes inflammation and prolongs transgene expression following delivery of adenoviral vectors to mouse liver and lung Hum Gene Ther 1996 7: 1555–1566
Yang YF et al. Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis Nat Genet 1994 7: 362–369
Wang Y, Krushel LA, Edelman GM . Targeted DNA recombination in vivo using an adenovirus carrying the cre recombinase gene Proc Natl Acad Sci USA 1996 93: 3932–3936
Armentano D et al. Characterization of an adenovirus gene transfer vector containing an E4 deletion Hum Gene Ther 1995 6: 1343–1353
Fisher KJ et al. Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis Virology 1996 217: 11–22
Kochanek S et al. A new adenoviral vector: replacement of all viral coding sequences with 28kb of DNA independently expressing both full-length dystrophin and β-galactosidase Proc Natl Acad Sci USA 1996 93: 5731–5736
Quantin B, Perricaudel LD, Tajbakhsh S, Mandel JL . Adenovirus as an expression vector in muscle cells in vivo Proc Natl Acad Sci USA 1992 89: 2581–2584
National Research Council . Guide for the Care and Use of Laboratory Animals National Academy Press: Washington DC 1996
Cepko C . Lineage analysis and immortalization of neural cells via retrovirus vectors. In: Boulton AA, Baker GB, Campagnoni AT (eds). Molecular Neurobiological Techniques, Neuromethods Humana: Clifton, NJ 1989
Redmond DE Jr et al. Neuropathological effects of an E1a, E3 deleted adenoviral vector injected into primate striatum: implications for clinical use Am Soc Gene Ther Abstr 1998 1: 152a (Abstr. 607)
Acknowledgements
We thank R Jude Samulski, Gene Therapy Center, University of North Carolina-Chapel Hill, for his helpful advice and comments on the manuscript and Richard Flavell, Department of Immunobiology at Yale, for his suggestions and support of this project. We also thank Mr Richard Anderson and the University of Iowa Vector Core, the staff of the St Kitts Biomedical Research Foundation, St Kitts, West Indies, for assistance with the animal experiments and surgery, especially Sean O’Loughlin, John Wharton, Ernell Nisbett, Franklyn Connor, Ricaldo Pike and Wellington Sutton, and Mrs Ianina Filopovich and Mrs Irena Shavytsky for technical assistance. The study was primarily supported by USPHS Grants MH57958 and NS24032 and the Axion Research Foundation, and partial support by the Medical Research Institute Council of Children’s Memorial Hospital, Chicago (Dr Bohn), the Carver Foundation (partial support for Dr Davidson), and Research Scientist Award from NIMH MH00643 to Dr Redmond.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lawrence, M., Foellmer, H., Elsworth, J. et al. Inflammatory responses and their impact on β-galactosidase transgene expression following adenovirus vector delivery to the primate caudate nucleus. Gene Ther 6, 1368–1379 (1999). https://doi.org/10.1038/sj.gt.3300958
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3300958
Keywords
This article is cited by
-
Gene transfer to the rhesus monkey brain using SV40-derived vectors is durable and safe
Gene Therapy (2011)
-
Transduction of Brain by Herpes Simplex Virus Vectors
Molecular Therapy (2007)
-
The potential application of gene therapy in the treatment of traumatic brain injury
Neurosurgical Review (2007)
-
Blood–brain Barrier Transport of Non-viral Gene and RNAi Therapeutics
Pharmaceutical Research (2007)
-
Selective gene expression in brain microglia mediated via adeno-associated virus type 2 and type 5 vectors
Gene Therapy (2003)